Abbott Laboratories (ABT)

Operating Expenses

$5.52B

Quarterly · Period ending: · USD

ABT logo

ABT Operating Expenses

Latest reported$5.52B
ABT Quarterly Operating Expenses ($0.00 → $5.52B)
High-resolution chart · PNG

ABT operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
5,522,000,000
4,441,000,000
4,286,000,000
4,308,000,000
4,236,000,000
3,756,000,000
3,608,000,000
3,608,000,000
3,619,000,000
3,637,000,000
3,394,000,000
3,356,000,000
3,434,000,000
3,405,000,000
3,530,000,000
3,506,000,000
3,441,000,000
3,484,000,000
3,762,000,000
3,438,000,000
3,377,000,000
3,437,000,000
3,273,000,000
2,876,000,000
2,839,000,000
3,098,000,000
2,978,000,000
3,008,000,000
3,010,000,000
3,131,000,000
2,907,000,000
2,934,000,000
3,030,000,000
3,108,000,000
3,046,000,000
2,573,000,000
2,670,000,000
2,840,000,000
1,942,000,000
1,954,000,000
2,230,000,000
2,221,000,000
2,167,000,000
2,195,000,000
2,223,000,000
2,206,000,000
1,693,000,000
2,042,000,000
2,092,000,000
2,116,000,000
2,285,649,000
2,097,000,000
2,274,000,000
2,331,000,000
4,334,203,000
4,086,000,000
3,956,000,000
4,006,000,000
4,457,110,000
5,249,000,000
3,800,000,000
3,781,000,000
4,092,861,000
3,752,000,000
3,676,116,000
2,892,000,000
3,142,095,000
2,761,000,000
2,695,000,000
2,721,688,000
3,028,991,000
2,748,274,000
2,787,736,000
2,637,990,000
2,541,670,000
2,586,122,000
2,379,930,000
2,405,925,000
3,606,279,000
2,493,386,000
2,569,734,000
1,949,557,000
1,936,975,000
1,858,996,000
1,797,050,000
1,724,277,000
1,898,163,000
1,536,114,000
1,837,869,000
1,643,706,000
1,766,707,000
1,526,795,000
2,088,639,000
1,402,232,000
1,574,358,000
1,360,343,000
1,465,200,000
1,248,367,000
1,505,944,000
1,395,652,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.